Table of Contents Author Guidelines Submit a Manuscript
ISRN Gastroenterology
Volume 2012 (2012), Article ID 480650, 8 pages
http://dx.doi.org/10.5402/2012/480650
Review Article

Transcatheter Arterial Chemoembolization: History for More than 30 Years

1Department of Oncology, West China Hospital of Sichuan University, Chengdu 610041, China
2State Key Laboratory of Biotherapy, West China Medical School, Sichuan University, Chengdu 610041, China

Received 28 June 2012; Accepted 2 August 2012

Academic Editors: A. Amedei and Y. Chao

Copyright © 2012 Yong-Song Guan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Hui Xie, Huaming Wang, Weimin An, Wei Ma, Ruping Qi, Bin Yang, Chunzi Liu, Yuanzhi Gao, Beibei Xu, and Wenhong Wang, “The Efficacy of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma in a Cohort of 487 Patients,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Jia-Yan Ni, Lin-Feng Xu, Wei-Dong Wang, Hong-Liang Sun, and Yao-Ting Chen, “Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: A meta-analysis,” World Journal Of Gastroenterology, vol. 20, no. 45, pp. 17206–17217, 2014. View at Publisher · View at Google Scholar
  • Wenbo Shao, Fengjuan Zhang, Ning Cong, Jinpeng Li, and Jinlong Song, “Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma,” Oncology Letters, vol. 8, no. 5, pp. 2263–2266, 2014. View at Publisher · View at Google Scholar
  • Kai Qu, Zhaoyong Yan, Yousheng Wu, Yibing Chen, Ping Qu, Xinsen Xu, Peng Yuan, Xiaojun Huang, Jinliang Xing, Hongxin Zhang, Chang Liu, and Jing Zhang, “Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 30, no. 5, pp. 925–932, 2015. View at Publisher · View at Google Scholar
  • Saleem Ahmed, Nurun Nisa de Souza, Wang Qiao, Meidai Kasai, Low Jee Keem, and Vishal G. Shelat, “Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization,” HPB Surgery, vol. 2016, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Yanpu Wu, Luming Wang, Kaili Zhang, Lixiao Zhou, Xiaobing Zhang, Xuecheng Jiang, and Chenggang Zhu, “ N -Butyl-2-cyanoacrylate-based injectable and in situ -forming implants for efficient intratumoral chemotherapy ,” Drug Delivery, vol. 24, no. 1, pp. 729–736, 2017. View at Publisher · View at Google Scholar
  • D. J. Pinato, J. Howell, R. Ramaswami, and R. Sharma, “Review article: delivering precision oncology in intermediate-stage liver cancer,” Alimentary Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar